LON:GENF Genflow Biosciences (GENF) Share Price, News & Analysis GBX 2.20 +0.04 (+1.95%) As of 06:53 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock About Genflow Biosciences Stock (LON:GENF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Genflow Biosciences alerts:Sign Up Key Stats Today's Range 2.15▼ 2.2050-Day Range 1.66▼ 2.9652-Week Range 0.55▼ 3.12Volume6.21 million shsAverage Volume2.75 million shsMarket Capitalization£11.78 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results. Read More Receive GENF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genflow Biosciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GENF Stock News HeadlinesGenflow Biosciences PLC Announces Exercise of Warrants and Issue of EquityMay 8, 2026 | finance.yahoo.comGenflow Biosciences PLC Announces Final ResultsMay 1, 2026 | finance.yahoo.comNobody Understands Why Trump Is Invading Iran (here’s the answer)Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.May 19 at 1:00 AM | Banyan Hill Publishing (Ad)Genflow surges 14% as animal health giants circle canine ageing gene therapyApril 28, 2026 | uk.finance.yahoo.comGenflow Biosciences PLC Announces Expansion of Confidentiality AgreementsApril 28, 2026 | finance.yahoo.comGenflow widens confidentiality agreements with animal health companies over dog gene therapy dataApril 28, 2026 | finance.yahoo.comGenflow Biosciences CEO on Acuitas collaboration: non-dilutive growth catalystApril 20, 2026 | uk.finance.yahoo.comGenflow Biosciences strikes LNP delivery deal with mRNA vaccine technology pioneerApril 20, 2026 | finance.yahoo.comSee More Headlines GENF Stock Analysis - Frequently Asked Questions How have GENF shares performed this year? Genflow Biosciences' stock was trading at GBX 1.85 at the beginning of the year. Since then, GENF shares have increased by 18.6% and is now trading at GBX 2.19. How were Genflow Biosciences' earnings last quarter? Genflow Biosciences plc (LON:GENF) issued its quarterly earnings data on Thursday, April, 30th. The company reported ($0.33) EPS for the quarter. Genflow Biosciences had a trailing twelve-month return on equity of 377.33% and a net margin of 840.76%. How do I buy shares of Genflow Biosciences? Shares of GENF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Genflow Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genflow Biosciences investors own include Aehr Test Systems (AEHR), Advanced Micro Devices (AMD), ARM (ARM), NIO (NIO), NVIDIA (NVDA) and PayPal (PYPL). Company Calendar Last Earnings4/30/2026Today5/19/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:GENF CIKN/A Webgenflowbio.com Phone44 32 4774 95881FaxN/AEmployees5Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£1.76 million Net Margins840.76% Pretax MarginN/A Return on Equity377.33% Return on Assets-58.66% Debt Debt-to-Equity RatioN/A Current Ratio0.61 Quick Ratio20.20 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 0.73 per share Price / Cash Flow3.00 Book ValueGBX 0.25 per share Price / Book8.86Miscellaneous Outstanding Shares535,653,000Free FloatN/AMarket Cap£11.78 million OptionableNot Optionable Beta2.11 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (LON:GENF) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredElon’s AI supercomputer just went live. Here’s my #1 stock.Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genflow Biosciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genflow Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
